Your browser doesn't support javascript.
loading
Hyperthermia Selectively Destabilizes Oncogenic Fusion Proteins.
Maimaitiyiming, Yasen; Wang, Qian Qian; Yang, Chang; Ogra, Yasumitsu; Lou, Yinjun; Smith, Clayton A; Hussain, Liaqat; Shao, Yi Ming; Lin, Jiebo; Liu, Jinfeng; Wang, Lingfang; Zhu, Yong; Lou, Haiyan; Huang, Yuan; Li, Xiaoxia; Chang, Kao-Jung; Chen, Hao; Li, Hongyan; Huang, Ying; Tse, Eric; Sun, Jie; Bu, Na; Chiou, Shih-Hwa; Zhang, Yan Fang; Hua, Hao Ying; Ma, Li Ya; Huang, Ping; Ge, Ming Hua; Cao, Feng-Lin; Cheng, Xiaodong; Sun, Hongzhe; Zhou, Jin; Vasliou, Vasilis; Xu, Pengfei; Jin, Jie; Bjorklund, Mikael; Zhu, Hong-Hu; Hsu, Chih-Hung; Naranmandura, Hua.
Afiliación
  • Maimaitiyiming Y; Department of Hematology of First Affiliated Hospital, and Department of Public Health, Zhejiang University School of Medicine, Hangzhou, China.
  • Wang QQ; Women's Hospital, Institute of Genetics, and Department of Environmental Medicine, Zhejiang University School of Medicine, Hangzhou, China.
  • Yang C; Zhejiang Laboratory for Systems and Precision Medicine, Zhejiang University Medical Center, Hangzhou, China.
  • Ogra Y; Department of Hematology of First Affiliated Hospital, and Department of Public Health, Zhejiang University School of Medicine, Hangzhou, China.
  • Lou Y; Zhejiang Laboratory for Systems and Precision Medicine, Zhejiang University Medical Center, Hangzhou, China.
  • Smith CA; Department of Hematology of First Affiliated Hospital, and Department of Public Health, Zhejiang University School of Medicine, Hangzhou, China.
  • Hussain L; Zhejiang Laboratory for Systems and Precision Medicine, Zhejiang University Medical Center, Hangzhou, China.
  • Shao YM; Department of Toxicology, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan.
  • Lin J; Department of Hematology, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Liu J; Blood Disorders and Cellular Therapies Center, University of Colorado Hospital, Denver, -Colorado.
  • Wang L; Department of Hematology of First Affiliated Hospital, and Department of Public Health, Zhejiang University School of Medicine, Hangzhou, China.
  • Zhu Y; Department of Pharmacology, Inner Mongolia Medical University, Hohhot, China.
  • Lou H; Women's Hospital, Institute of Genetics, and Department of Environmental Medicine, Zhejiang University School of Medicine, Hangzhou, China.
  • Huang Y; Women's Hospital, Institute of Genetics, and Department of Environmental Medicine, Zhejiang University School of Medicine, Hangzhou, China.
  • Li X; Women's Hospital, Institute of Genetics, and Department of Environmental Medicine, Zhejiang University School of Medicine, Hangzhou, China.
  • Chang KJ; Department of Environmental Sciences, Yale University School of Public Health, New Haven, Connecticut.
  • Chen H; Department of Hematology, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Li H; Zhejiang Province Lishui Municipal Hospital, Lishui, China.
  • Huang Y; Department of Hematology, the First Affiliated Hospital, Harbin Medical University, Harbin, China.
  • Tse E; Institute of Clinical Medicine, National Yang Ming University, Taipei, Taiwan, China.
  • Sun J; Division of Newborn Medicine and Program in Epigenetics, Children's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Bu N; Department of Chemistry, the University of Hong Kong, Hong Kong, China.
  • Chiou SH; Institute of Genetics, Zhejiang University, and Department of Genetics, School of Medicine, Zhejiang University, Hangzhou, China.
  • Zhang YF; Department of Medicine, the University of Hong Kong and Queen Mary Hospital, Hong Kong, China.
  • Hua HY; Department of Hematology, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Ma LY; Women's Hospital, Zhejiang University School of Medicine, -Hangzhou, Zhejiang, China.
  • Huang P; Taipei Veterans General Hospital Department of Medical Research, Taipei, Taiwan, China.
  • Ge MH; Department of Hematology, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Cao FL; Southern Medical University, Guangzhou, China.
  • Cheng X; Department of Hematology, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Sun H; Zhejiang Provincial People's Hospital, Hangzhou, China.
  • Zhou J; Zhejiang Provincial People's Hospital, Hangzhou, China.
  • Vasliou V; Department of Hematology, the First Affiliated Hospital, Harbin Medical University, Harbin, China.
  • Xu P; Women's Hospital, Zhejiang University School of Medicine, -Hangzhou, Zhejiang, China.
  • Jin J; Department of Chemistry, the University of Hong Kong, Hong Kong, China.
  • Bjorklund M; Department of Hematology, the First Affiliated Hospital, Harbin Medical University, Harbin, China.
  • Zhu HH; Department of Environmental Sciences, Yale University School of Public Health, New Haven, Connecticut.
  • Hsu CH; Institute of Genetics, Zhejiang University, and Department of Genetics, School of Medicine, Zhejiang University, Hangzhou, China.
  • Naranmandura H; Department of Hematology, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Blood Cancer Discov ; 2(4): 388-401, 2021 Jul.
Article en En | MEDLINE | ID: mdl-34661159
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Promielocítica Aguda / Hipertermia Inducida Tipo de estudio: Prognostic_studies Idioma: En Revista: Blood Cancer Discov Año: 2021 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Promielocítica Aguda / Hipertermia Inducida Tipo de estudio: Prognostic_studies Idioma: En Revista: Blood Cancer Discov Año: 2021 Tipo del documento: Article País de afiliación: China